Wellbeing Nutrition hires Varun Kandhari to drive 2024 expansion plans
Wellbeing Nutrition hires Varun Kandhari to drive 2024 expansion plans
Wellbeing Nutrition hires Varun Kandhari to drive 2024 expansion plans
Wellbeing Nutrition has named Varun Kandhari as its new chief marketing and growth officer. The appointment comes as the company pushes for rapid expansion in 2024. Kandhari brings nearly two decades of experience in marketing and business leadership to the role. Kandhari's career spans major brands across India and South Asia. He spent ten years at Mars Wrigley, where he drove business growth twelvefold while improving profitability. Before that, he worked at Unilever in the home and personal care sector.
Most recently, he served as chief marketing officer and strategy lead for Davide Campari-Milano N.V. in the same region. His track record in scaling businesses aligns with Wellbeing Nutrition's ambitions to double revenue and grow its global presence this year.
Founded in 2019 by Avnish Chhabria, the company later welcomed Saurabh Kapoor as co-founder in 2021. Kapoor has now expressed enthusiasm about Kandhari joining the team. The new executive has also shared his eagerness to support the brand's next phase of development. The hire reflects Wellbeing Nutrition's focus on accelerating growth in a competitive market. Kandhari's experience in driving profitability and expansion will play a key role in the company's plans. His leadership is expected to help meet the target of doubling revenue and widening international reach.
German nursing care reform faces delay as DAK-Gesundheit demands major revisions
A last-minute plea to halt the reform exposes deep flaws in Germany's care system. Will the government rewrite the rules—or risk financial chaos for families and towns?
Region's healthcare transformation brings new hospitals and cutting-edge upgrades
From rural clinics to urban polyclinics, this region's healthcare overhaul is setting new standards. Discover how 149 new facilities and global-trained doctors are reshaping patient care.
FDA's peptide safety review sparks conflict-of-interest concerns this July
From muscle growth to anti-aging, peptides promise miracles—but can the FDA's review be trusted with insiders profiting from the same drugs? A deep dive into the controversy.
Debt repayments now outpace healthcare spending in poorer nations
Kenya spends 29% of revenue on debt—three times its healthcare budget. The IMF's austerity push deepens inequality and strains public services.